| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | US20060287291 such as 2-Methoxy-5-methyl-N-[7-(piperazin-1-ylcarbonyl)-1-benzofuran-5-yl]benzenesulfonamide for treating disorders related to 5-HT6 receptor related disorders such as obesity, type II diabetes, anxiety, depression, panic attacks, memory/sleep/cognitive disorders, epilepsy, obsessive compulsive disorder |
| 12/21/2006 | US20060287275 Using 5'-sulfoxyoxy adenosine in therapy for tachycardia, cardiovascular disorders, angina, myocardial infraction , antilipemic agents |
| 12/21/2006 | US20060287251 Combination therapy for glycaemic control |
| 12/21/2006 | US20060287236 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 12/21/2006 | US20060287235 Crystallization of IGF-1 |
| 12/21/2006 | US20060287223 Remodeling and glycoconjugation of peptides |
| 12/21/2006 | US20060286168 Process for producing coated preparation |
| 12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
| 12/21/2006 | US20060286107 Parathyroid hormone antibodies and related methods |
| 12/21/2006 | US20060286087 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 12/21/2006 | DE19843489B4 Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung Benzoylguanidine-derivatives having advantageous properties, to processes for their preparation and their use in the manufacture of medicinal products and pharmaceutical preparation containing them |
| 12/21/2006 | DE102005029382B3 New alkoxymethylyl substituted benzoic acid derivatives are peroxisome proliferation activated receptor agonists used for treating and/or preventing e.g. diabetes mellitus, dyslipidemia and disturbances in fatty acid metabolism |
| 12/21/2006 | DE102005026762A1 Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen Azolopyridin-2-one derivatives as inhibitors of lipases, and phospholipases |
| 12/21/2006 | CA2612324A1 N-acyl derivatives of amino acids, a process for preparation thereof, a pharmaceutical composition and use thereof as antiallergic, anti-inflammatory and hypolipidemic agents |
| 12/21/2006 | CA2612063A1 Oxyntomodulin analogues and their effects on feeding behaviour |
| 12/21/2006 | CA2611910A1 Anthranilic acid derivatives |
| 12/21/2006 | CA2611529A1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 12/21/2006 | CA2610383A1 Benzofuranyl derivatives as 5-ht6-receptor inhibitors |
| 12/21/2006 | CA2610188A1 Oxadiazole derivatives as dgat inhibitors |
| 12/20/2006 | EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications |
| 12/20/2006 | EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative |
| 12/20/2006 | EP1733734A2 Placental alkaline phosphatase to control diabetes |
| 12/20/2006 | EP1733733A1 Regulator for adiponectin receptor expression |
| 12/20/2006 | EP1733732A1 Insulin resistance improving agent |
| 12/20/2006 | EP1733728A2 Use of 2-alkoxyphenyl substituted imidazotriazinones as inhibitors of phosphodiesterase |
| 12/20/2006 | EP1733721A2 Use of astaxanthin or esters thereof as a phosphodiesterase inhibitor |
| 12/20/2006 | EP1732933A1 Compounds and methods for treating dyslipidemia |
| 12/20/2006 | EP1732885A1 Lactams as conformationally constrained peptidomimetic inhibitors |
| 12/20/2006 | EP1732586A1 Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continunous infusion |
| 12/20/2006 | EP1732543A2 Tetra-cyclic carboline deratives for inhibiting angiogenesis |
| 12/20/2006 | EP1732538A1 Use of a serine palmitoyltransferase (spt) inhibitor to treat atherosclerosis and dyslipidemia |
| 12/20/2006 | EP1732531A2 Amines and amides for the treatment of diseases |
| 12/20/2006 | EP1651220B1 2-[4- (2-hydroxymethyl-phenylamino)-piperidin-1-yl] - n-(9h-carbazol-3-yl) - acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 12/20/2006 | EP1648458B1 2-[4(phenylamino)-piperidin-1-yl]-n-phenyl-acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 12/20/2006 | EP1562617B1 New use of pipataline |
| 12/20/2006 | EP1506200B1 Diazabicyclic biaryl derivatives |
| 12/20/2006 | EP1456171B1 Substituted cyclohexane derivatives |
| 12/20/2006 | EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors |
| 12/20/2006 | EP1390362B1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 12/20/2006 | EP1357903B1 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY|PHENOXY)-2-(4-METHOXYPHENYL) BENZO b|THIOPHENE AND SALTS THEREOF |
| 12/20/2006 | EP1353696B1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 12/20/2006 | EP1272616B1 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
| 12/20/2006 | EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 12/20/2006 | EP1235835B1 Chromium-histidine complexes as nutrient supplements |
| 12/20/2006 | CN1882557A 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
| 12/20/2006 | CN1882554A Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 12/20/2006 | CN1882551A Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 12/20/2006 | CN1882538A Substituted sulfonamide-indole-2-carboxylic acid derivatives as PAI-1 inhibitors |
| 12/20/2006 | CN1882533A 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 12/20/2006 | CN1882526A Process for the preparation of voglibose |
| 12/20/2006 | CN1882524A 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 12/20/2006 | CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 12/20/2006 | CN1880304A Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 12/20/2006 | CN1879891A Method for expressing human insulin for reducing blood sugar by transgenic lucid ganoderma |
| 12/20/2006 | CN1879851A Quality detection method of a compound Chinese medicine |
| 12/20/2006 | CN1879847A A Chinese herbal medicament for treating diabetes |
| 12/20/2006 | CN1879839A Mongolian medicine Baolier for treating hyperlipemia and method for preparing same |
| 12/20/2006 | CN1879796A A multi-element balanced health product |
| 12/20/2006 | CN1879794A A medicine for treating diabetes with deficiency of both qi and yin |
| 12/20/2006 | CN1879793A A medicine for treating dryness heat exuberance type diabetes |
| 12/20/2006 | CN1879789A A Chinese medicinal composition for treating blood heat type obesity |
| 12/20/2006 | CN1879783A A medicine for treating diabetes |
| 12/20/2006 | CN1879765A Method for preparing medicine to treat hyperlipemia |
| 12/20/2006 | CN1879753A Medicine for treating diabetes of blood stasis complicated kidney spleen deficiency type |
| 12/20/2006 | CN1879743A Oral liquid of litchi seed and method for making same |
| 12/20/2006 | CN1879742A Vessel-dredging fat-reducing soft capsule preparation and preparation method thereof |
| 12/20/2006 | CN1879724A A method for preparing blood fat-reducing natural product |
| 12/20/2006 | CN1879702A A medicine for preventing and treating diabetes, preparation method and application thereof |
| 12/20/2006 | CN1879699A Chinese medicinal composition for treating obesity and preparation method thereof |
| 12/20/2006 | CN1879683A An health food capable of lowering blood pressure and blood sugar and preparation method thereof |
| 12/20/2006 | CN1879675A A method for extracting effective parts to treat cardiovascular and cerebraovascular diseases |
| 12/20/2006 | CN1879666A Method for producing silicon supplementation preparation by silicon enriched plants |
| 12/20/2006 | CN1879657A Biological fat-reducing health product, preparation method and application thereof |
| 12/20/2006 | CN1879648A A multi-vitamin lyophilized formulation and preparation method thereof |
| 12/20/2006 | CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 12/20/2006 | CN1879629A Estrogen replacement therapy |
| 12/20/2006 | CN1879624A 5-ht 1a receptor subtype agonists |
| 12/20/2006 | CN1879619A Cancer treatment |
| 12/20/2006 | CN1879610A Method for preparing oral administered sustained-release peptide micro capsule |
| 12/20/2006 | CN1879609A A method for preparing silk fibroin Vitamin E contained micro capsule |
| 12/20/2006 | CN1879507A Water containing soluble fiber |
| 12/20/2006 | CN1879488A Extraction process of blood sugar-decreasing tea |
| 12/20/2006 | CN1291008C Fungus strain and its application |
| 12/20/2006 | CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/20/2006 | CN1290847C Aza-arylpiperazines |
| 12/20/2006 | CN1290846C Pyrazolo[1,5-a]pyridines and medicaments containing thereof |
| 12/20/2006 | CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 12/20/2006 | CN1290575C Method for preparing technical product of lowering sugar of balsam pear containing active protein |
| 12/20/2006 | CN1290529C Medicine for treating gout, hyperuricemia and hyperlipemia and preparation method thereof |
| 12/20/2006 | CN1290524C Nutrition metabolic acid-base balance regulating agent and its producing process |
| 12/20/2006 | CN1290517C Preparation method of combination of propolis |
| 12/20/2006 | CN1290516C Compound medicine compatibility method of ion pair agent and vanadium compound and the application thereof |
| 12/20/2006 | CN1290515C Poly(allylamine hydrochloride) with low salt content |
| 12/20/2006 | CN1290509C New use of saponin compound for treating cardiovascular disease |
| 12/20/2006 | CN1290444C Intestinal absorbing fully nutrient emulsion for phymatostio patient and method for preparation same |
| 12/20/2006 | CN1290443C Cellulosefree intestinal absorbing nutrient emulsion and its preparing method |
| 12/20/2006 | CN1290441C Rye-red yeast vinegar soft capsule and its preparing method |
| 12/19/2006 | USRE39436 Interventions to mimic the effects of calorie restriction |
| 12/19/2006 | US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery |